> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Mallinckrodt’s NDA for Terlipressin
- URL: https://www.fdaweb.com/panel-to-discuss-mallinckrodts-nda-for-terlipressin/
- Published: 2020-07-09T12:00:00.000Z
- Updated: 2026-09-14T16:20:36.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147163

*Federal Register* notice: FDA has announced a 7/15 Cardiovascular and Renal Drugs Advisory Committee online meeting. Panel members are scheduled to discuss a Mallinckrodt Pharmaceuticals NDA for terlipressin, indicated for treating hepatorenal syndrome Type 1\. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-07-08/pdf/2020-14719.pdf?ref=fdaweb.com).